Rapid external modular expansion of an existing vaccine bulk manufacturing facility

Time savings and cost predictability are always critical when a leading global pharmaceuticals company expands production. 

KeyPlants off-site modular approach provided key business benefits to this project in three areas: 

1. Speed, with a rapid delivery model
   
   
2. Cost Effectiveness, with higher level of cost certainty, while providing a low total cost of ownership
   
   
3. Optimal Configuration & Capacity by modularizing exactly what was needed by the business.

The 4-story modular building (1,500 m²/16,150 SF) with integrated cold room and buffer preparation process areas has been designed and delivered in 13 months. All design was done in a 3D model, off-site fabrication and commissioning were performed at our factory during the COVID19 restrictions in 2020-2021, all review meetings with the client were held via digital technology.